EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
10 hedge funds and large institutions have $33.1M invested in ESSA Pharma in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
–
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$289K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.5K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EAM
1
Eventide Asset Management
Boston,
Massachusetts
| $7.41M | – | – | – |
|
|
DM
2
Deerfield Management
New York
| $6.62M | – | – | – |
|
|
CV
3
Clarus Ventures
Cambridge,
Massachusetts
| $6.62M | – | – | – |
|
|
OFM
4
Omega Fund Management
Boston,
Massachusetts
| $5.29M | – | – | – |
|
|
AIC
5
AWM Investment Company
New York
| $5.29M | – | – | – |
|
|
ACP
6
Acuta Capital Partners
Redwood City,
California
| $1.88M | – | – | – |
|
7
Royal Bank of Canada
Toronto,
Ontario, Canada
| $19K | – | – | – |
|
8
Bank of Montreal
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $1K | -$4.5K | -90 | -82% |
|
|
DCM
10
DAFNA Capital Management
Los Angeles,
California
| – | -$289K | -4,902 | Closed |
|